Zobrazuji výsledky 1 - 3 z 3 pro vyhledávání 'Yakir Moshe', doba hledání: 0,02 s. Upřesnit hledání
  1. 1
    Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience

    Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience Autor Ron Ram, Christof Scheid, Odelia Amit, Jens Markus Chemnitz, Yakir Moshe, Michael Hallek, Dominik Wolf, Irit Avivi, Udo Holtick

    Vydáno 2019-09-01
    Získat plný text
    Článek
  2. 2
    P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS

    P571: OUTPATIENT INITIATION OF VENETOCLAX-AZACITIDINE FOR SELECTED ACUTE MYELOID LEUKEMIA PATIENTS IS FEASIBLE AND SAFE: A REAL WORLD SINGLE CENTER ANALYSIS Autor Roi Gat, Miri Neeman, Shai Levi, Mor Levi, Nili Eilati, Yotam Bronstein, Tamir Shragai, Tsipora Neuman, Yafit Segman, Roy Vitkon, Moshe Mittelman, Irit Avivi, Yakir Moshe

    Vydáno 2023-08-01
    Získat plný text
    Článek
  3. 3
    P560: IMPROVEMENT IN OVERALL AND RELAPSE FREE SURVIVAL OF AML PATIENTS OVER THE AGE OF 75 SINCE THE APPROVAL OF VENETOCLAX IN A REAL-WORLD SINGLE CENTER STUDY.

    P560: IMPROVEMENT IN OVERALL AND RELAPSE FREE SURVIVAL OF AML PATIENTS OVER THE AGE OF 75 SINCE THE APPROVAL OF VENETOCLAX IN A REAL-WORLD SINGLE CENTER STUDY. Autor Yakir Moshe, Shai Levi, Miri Neeman, Roi Gat, Mor Levi, Nili Eilati, Tamir Shragai, May Basood, Yafit Segman, Yaeli Baron, Efrat Luttwak, Tsipora Neuman, Roy Vitkon, Moshe Mittelman, Irit Avivi

    Vydáno 2023-08-01
    Získat plný text
    Článek

Vyhledávací nástroje: